Safety-Based Drug Withdrawals
"Safety-Based Drug Withdrawals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.
| Descriptor ID |
D056737
|
| MeSH Number(s) |
I01.880.604.605.250.812 N04.452.706.310.750 N06.850.210.637.700
|
| Concept/Terms |
Safety-Based Drug Withdrawals- Safety-Based Drug Withdrawals
- Drug Withdrawal, Safety-Based
- Drug Withdrawals, Safety-Based
- Safety Based Drug Withdrawals
- Drug Withdrawals Due to Safety
- Safety-Based Drug Withdrawal
- Safety Based Drug Withdrawal
- Drug Withdrawal Due to Safety
|
Below are MeSH descriptors whose meaning is more general than "Safety-Based Drug Withdrawals".
Below are MeSH descriptors whose meaning is more specific than "Safety-Based Drug Withdrawals".
This graph shows the total number of publications written about "Safety-Based Drug Withdrawals" by people in this website by year, and whether "Safety-Based Drug Withdrawals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Safety-Based Drug Withdrawals" by people in Profiles.
-
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):680-684.
-
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30; 70(17):651-656.
-
[Pharmacovigilance update]. Rev Med Suisse. 2021 Jan 13; 17(720-1):80-84.
-
De-escalation of medical therapy in inflammatory bowel disease. Curr Opin Pharmacol. 2020 12; 55:73-81.
-
Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study. Vaccine. 2020 10 14; 38(44):6882-6888.
-
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! Eur J Obstet Gynecol Reprod Biol. 2020 Sep; 252:300-302.
-
Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev. 2017 09 18; 9:CD012143.
-
France to prosecute its drug regulator and Servier in scandal over diabetes drug. BMJ. 2017 09 11; 358:j4231.
-
Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev. 2017 06 06; 6:CD012143.